Скачать или смотреть Metformin Reduces AFib Episodes in Overweight/Obese Adults: New Research

Exciting news for those with atrial fibrillation (AFib) and obesity! A recent study suggests that the diabetes drug metformin can significantly reduce AFib episodes after ablation. This video explores the findings, which show that metformin, when added to standard care, can help overweight or obese adults stay free of AFib episodes for longer. Discover the potential benefits and side effects, and learn why this research is a promising step forward in AFib treatment.
Key Takeaways:
Metformin, a common diabetes medication, may reduce AFib episodes in overweight/obese adults without diabetes.
The study found that 78% of the metformin group had no AFib episodes over 30 seconds, compared to 58% in the usual-care group.
Metformin users had fewer repeat ablations and electric shocks, and less frequent AFib episodes during monitoring.
Weight loss was not the primary reason for metformin's success, as weight changes were minimal.
Further research is needed to compare metformin with other diabetes medications in this context.